Programmed Cell Death Ligand 1 Expression In A Case Of Poorly Differentiated Lymphocyte-Rich Hepatocellular Carcinoma

Ginji Omori,Takahiro Osuga,Koji Miyanishi,Kota Hamaguchi,Shingo Tanaka,Hiroyuki Ohnuma,Kazuyuki Murase,Kohichi Takada,Minoru Nagayama,Yasutoshi Kimura,Ichiro Takemasa,Yasuhiro Kikuchi,Toshihiko Torigoe,Junji Kato

CLINICAL CASE REPORTS（2021）

引用 2|浏览8

暂无评分

摘要

Our pathological study of a case of poorly differentiated lymphocyte-rich hepatocellular carcinoma suggested that immune checkpoint inhibitor may be an effective therapy. The histological type is an important factor in determining treatment choices.

查看译文

关键词

hepatocellular carcinoma, immune checkpoint inhibitors, lymphocyte-rich, lymphoepithelial, hepatocellular carcinoma, programmed cell death ligand 1

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要